Geoffrey Mackay

Insider Reports History

Identity 1 identity field
Location
Cambridge, MA
SEC source record 1 source field
Owner filing signature
/s/ Mary Kay Fenton, attorney-in-fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Geoffrey Mackay

Form 4 holding President & CEO, Director

AVROBIO, Inc.

Security class
Restricted Stock Unit
Shares / value
300,667
Estimated value
$360,981
Report date
08 Feb 2023
Price
$1.20
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Talaris Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,500
Estimated value
Report date
13 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Geoffrey Mackay

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .